• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 13, Issue 3
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 13, Issue 3
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      A Randomized Clinical Trial Study: Anti-Oxidant, Anti-hyperglycemic and Anti-Hyperlipidemic Effects of Olibanum Gum in Type 2 Diabetic Patients

      (ندگان)پدیدآور
      Azadmehr, AbbasZiaee, AmirGhanei, LalehFallahhuseini, hasanHajiaghaee, Rezatavakoli-far, BaharehKordafshari, Gholamreza
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      1.090 مگابایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Research article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Diabetes is a common metabolic disease in the world that has many adverse effects. Olibanum gum resin (from trees of the genus Boswellia) has traditionally been used in the treatment of various diseases such as diabetes. The aim of this study was the comparison of Olibanum gum resin effect with placebo on the treatment of type 2 diabetes. Inclusion criteria was diabetic patients with fasting blood sugar (FBS) =140-200 mg/dL. This study has been designed as double-blined clinical trial on 71 patients with type 2 diabetes and the patients randomly were divided to interventional and placebo groups. The patients on standard anti-diabetic therapy (metformin) treated with Olibanum gum resin (400 mg caps) and placebo tow times per day for 12 weeks, respectively. At the end of 12 weeks the FBS, HbA1c, Insulin, total Cholesterol (Chol), LDL, Triglyceride (TG), HDL and other parameters were measured. The Olibanum gum resin lowered the FBS, HbA1c, Insulin, Chol, LDL and TG levels significantly (p
      کلید واژگان
      Olibanum gum resin
      Diabetes
      Hyperglycemia
      Hyperlipidemia
      patients
      Pharmacognosy
      Pharmacotherapy (Clinical Pharmacy)

      شماره نشریه
      3
      تاریخ نشر
      2014-07-01
      1393-04-10
      ناشر
      School of Pharmacy, Shahid Beheshti University of Medical Sciences
      سازمان پدید آورنده
      Metabolic Disease Research Center, Department of Immunology, Qazvin University of Medical Sciences, Qazvin, Iran
      Metabolic Disease Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
      Metabolic Disease Research Center, Department of Immunology, Qazvin University of Medical Sciences, Qazvin, Iran
      Pharmacology and Applied Medicine, Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
      Pharmacognosy and Pharmacy, Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
      Department of Pharmacology, Alborz University of Medical Sciences, Karaj, Iran.
      Tehran University of Medical Sciences, Tehran, Iran.

      شاپا
      1735-0328
      1726-6890
      URI
      https://dx.doi.org/10.22037/ijpr.2014.1544
      http://ijpr.sbmu.ac.ir/article_1544.html
      https://iranjournals.nlai.ir/handle/123456789/313249

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب